Brief: Scandinavian ChemoTech: Case Series Study
Sept 16 (Reuters) - Scandinavian ChemoTech AB CMOTECb.ST :
* SAID ON THURSDAY CASE SERIES STUDY INDICATES TSE CAN BE
PERFORMED WITHOUT GENERAL ANAESTHESIA
* STUDY INCLUDED COHORT OF 21 PATIENTS WHO RECEIVED TSE
THERAPY
UNDER SEDATION AND PAIN RELIEF
Source text for Eikon: ID:nWkr6KhMYg
Further company coverage: CMOTECb.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Scandinavian ChemoTech AB
See all newsBrief: Chemotech Enters Strategic Partnership With University Of Copenhagen's Veterinary Hospitals
Brief: Scandinavian Chemotech Secures SEK 6 Mln Growth Loan
Brief: ChemoTech: Outcome Of Directed Issue
Sweden's ChemoTech Q1 net sales rise, loss narrows on US operation improvement
Brief: ChemoTech Q1 Sales SEK 2.798 Million